← Leaderboards
Heather Giles
Vapogenix, Inc.
$1,019,551
Attributed
$1,131,418
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $907.7K · FY2018–20$1M$750K$500K$250K$0
'18
'19
'20
Funding mix
By agency
NIH$1,131,418 · 2
By mechanism
R44$907,683 · 1
R43$223,735 · 1
Top collaborators
- Darren G Woodside1 shared
Others in their field
Other Emerging Leaders on “Effective Therapy”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Leonard Freedman · Leidos Biomedical Research, Inc.$69,114,853
- Peter W Pisters · University Of Tx Md Anderson Can Ctr$56,084,949
- Yunda Huang · Fred Hutchinson Cancer Center$51,679,442
Research focus
Effective TherapyFormulationCytokineDrug DevelopmentFamilyAmericanAnalgesicsAdhesionsAbsence Of Pain SensationAcuteAdhesion ReceptorAntiinflammatory EffectArthritisBaseBurn InjuryCase StudyCell AdhesionAnestheticsCell MotilityAnimal ModelCellsCharacteristicsAffectFunding
Grant awards (2)
Development of Formulated Sevoflurane as a Novel Topical Treatment for Painful Inflammatory Conditions$907,683
R44 · FY2020 · AR · contact PI
Novel Use of Volatile Anesthetics as Topical Treatment for Painful Inflammatory Conditions: Interactions with Integrins and In Vivo Anti-inflammatory Effects.$223,735
R43 · FY2018 · AR · contact PI